急性肾损伤的肾脏替代治疗  

Renal replacement therapy in acute kidney injury

作　　者：徐天华[1] 姚丽[1] 

机构地区：[1]中国医科大学附属第一医院肾内科,辽宁沈阳110001

出　　处：《中国实用内科杂志》2016年第6期449-452,共4页Chinese Journal of Practical Internal Medicine

基　　金：国家"十二五"科技支撑计划项目子课题(2011-BAI10B02);辽宁省科技厅社会发展攻关计划(2013225303);辽宁省教育厅高等学校科研项目(L2011134)

摘　　要：肾脏替代治疗(RRT)是急性肾损伤患者,尤其是危重患者的重要治疗手段。对于危重患者而言,RRT已经是一种常规的支持治疗。连续性肾脏替代治疗作为新技术仍是研究的焦点。重症监护病房(ICU)患者RRT不仅仅是肾脏替代,更是对其他器官的支持治疗。但目前关于最佳的RRT的开始时机、模式、治疗剂量仍然存在争议。该文旨在讨论这些争议问题,为临床工作提出可行的建议以及未来须进一步研究的方向。Renal replacement therapies （RRTs） represent a cornerstone in the management of AKI patients, especially in severe acute kidney injury. Continuous RRTs have been a major focus of new technological and treatment strategies. RRT is being used increasingly in the intensive care unit, not only for renal indications but also for other organ-supportive strategies. Many of the fundamental questions regarding optimal management of RRT, such as the timing of initiation of renal replacement therapy, the selection of the specific modality of RRT, and prescription of intensity of therapy still remain controversial. We discuss several controversial issues, providing some practical recommendations, and possible suggestions of research agenda for the future.

关 键 词：急性肾损伤 肾脏替代治疗 

分 类 号：R692[医药卫生—泌尿科学]